CD4 and Alzheimer disease: Studies on AD mouse models have shown that CD4+CD25+ Treg lymphocytes are the main modulators of immune responses, maintaining an immunological tolerance to self antigens, slowing down the progression of AD and modulating the microglial response to amyloid deposition [178].